Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed)
The summary for the Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed): The purpose of this Notice of Funding Opportunity (NOFO) is to establish an infrastructure to facilitate coordination, collection, management, and dissemination of biospecimen materials to advance clinical research of co-occurring conditions in individuals with Down syndrome. This effort is intended to leverage NIH's investment in the INCLUDE Project, the INCLUDE Data Coordinating Center (DCC), and support for current NIH-funded Down syndrome biospecimen repositories. The Federated Biospecimen Repository will use a cooperative agreement mechanism. In addition, this resource will be a companion to the Down Syndrome Cohort Research Sites (DS-CRS) and the Down Syndrome Clinical Cohort Coordinating Centers (DS-4C) within the Down Syndrome Cohort Development Program (DS-CDP) (for details see: RFA-OD-23-052 and RFA-OD-23-053).
| Federal Grant Title: | Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed) |
| Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
| Grant Categories: | Food and Nutrition Health Income Security and Social Services |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | RFA-OD-24-004 |
| Type of Funding: | Cooperative Agreement |
| CFDA Numbers: | 93.172, 93.847, 93.865, 93.866 |
| CFDA Descriptions: | Information not provided |
| Current Application Deadline: | December 15th, 2023 |
| Original Application Deadline: | December 15th, 2023 |
| Posted Date: | October 19th, 2023 |
| Creation Date: | October 19th, 2023 |
| Archive Date: | January 20th, 2024 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | $3,750,000 |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
| Last Updated: | October 20th, 2023 |
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Link to Full Grant Announcement
- https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-24-004.html
- Grant Announcement Contact
- NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials N...
- • Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, C...
- • Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants ...
- • IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)
- • GREGoRi Innovation Projects (U01 Clinical Trial Optional)
- • Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
- • Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
- • Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
- More Grants from the National Institutes of Health
- • Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...
- • NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
- • Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Researc...
